These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24928479)

  • 41. Effects of a selective serotonin reuptake inhibitor escitalopram on the cutaneous silent period: a randomized controlled study in healthy volunteers.
    Pujia F; Serrao M; Brienza M; Vestrini E; Valente GO; Coppola G; Pierelli F
    Neurosci Lett; 2014 Apr; 566():17-20. PubMed ID: 24589881
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of escitalopram in the treatment of social anxiety disorder: A meta-analysis versus placebo.
    Baldwin DS; Asakura S; Koyama T; Hayano T; Hagino A; Reines E; Larsen K
    Eur Neuropsychopharmacol; 2016 Jun; 26(6):1062-9. PubMed ID: 26971233
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Randomized Double-Blind Placebo-Controlled Trial of Combined Escitalopram and Memantine for Older Adults With Major Depression and Subjective Memory Complaints.
    Lavretsky H; Laird KT; Krause-Sorio B; Heimberg BF; Yeargin J; Grzenda A; Wu P; Thana-Udom K; Ercoli LM; Siddarth P
    Am J Geriatr Psychiatry; 2020 Feb; 28(2):178-190. PubMed ID: 31519517
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.
    Clayton AH; Croft HA; Horrigan JP; Wightman DS; Krishen A; Richard NE; Modell JG
    J Clin Psychiatry; 2006 May; 67(5):736-46. PubMed ID: 16841623
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential impact of selective serotonin reuptake inhibitors on platelet response to clopidogrel: a randomized, double-blind, crossover trial.
    Hirsh-Rokach B; Spectre G; Shai E; Lotan A; Ritter A; Al-Aieshy F; Malmström RE; Varon D; Alcalai R
    Pharmacotherapy; 2015 Feb; 35(2):140-7. PubMed ID: 25689244
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Escitalopram treatment of depression in human immunodeficiency virus/acquired immunodeficiency syndrome: a randomized, double-blind, placebo-controlled study.
    Hoare J; Carey P; Joska JA; Carrara H; Sorsdahl K; Stein DJ
    J Nerv Ment Dis; 2014 Feb; 202(2):133-7. PubMed ID: 24469525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Actual driving performance and psychomotor function in healthy subjects after acute and subchronic treatment with escitalopram, mirtazapine, and placebo: a crossover trial.
    Wingen M; Bothmer J; Langer S; Ramaekers JG
    J Clin Psychiatry; 2005 Apr; 66(4):436-43. PubMed ID: 15816785
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness: a double-blind, placebo-controlled study.
    Dunlop BW; Crits-Christoph P; Evans DL; Hirschowitz J; Solvason HB; Rickels K; Garlow SJ; Gallop RJ; Ninan PT
    J Clin Psychopharmacol; 2007 Dec; 27(6):614-9. PubMed ID: 18004129
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of generalized anxiety disorder with escitalopram: pooled results from double-blind, placebo-controlled trials.
    Goodman WK; Bose A; Wang Q
    J Affect Disord; 2005 Aug; 87(2-3):161-7. PubMed ID: 15982747
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
    Waugh J; Goa KL
    CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Escitalopram treatment for depressive disorder following acute coronary syndrome: a 24-week double-blind, placebo-controlled trial.
    Kim JM; Bae KY; Stewart R; Jung BO; Kang HJ; Kim SW; Shin IS; Hong YJ; Kim JH; Shin HY; Kang G; Ahn Y; Kim JK; Jeong MH; Yoon JS
    J Clin Psychiatry; 2015 Jan; 76(1):62-8. PubMed ID: 25375836
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Do You Believe It? Verbal Suggestions Influence the Clinical and Neural Effects of Escitalopram in Social Anxiety Disorder: A Randomized Trial.
    Faria V; Gingnell M; Hoppe JM; Hjorth O; Alaie I; Frick A; Hultberg S; Wahlstedt K; Engman J; Månsson KNT; Carlbring P; Andersson G; Reis M; Larsson EM; Fredrikson M; Furmark T
    EBioMedicine; 2017 Oct; 24():179-188. PubMed ID: 29033138
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Normalizing effects of modafinil on sleep in chronic cocaine users.
    Morgan PT; Pace-Schott E; Pittman B; Stickgold R; Malison RT
    Am J Psychiatry; 2010 Mar; 167(3):331-40. PubMed ID: 20080983
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of citalopram and escitalopram on fMRI response to affective stimuli in healthy volunteers selected by serotonin transporter genotype.
    Henry ME; Lauriat TL; Lowen SB; Churchill JH; Hodgkinson CA; Goldman D; Renshaw PF
    Psychiatry Res; 2013 Sep; 213(3):217-24. PubMed ID: 23845563
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early non-response in patients with severe depression: escitalopram up-titration versus switch to duloxetine.
    Bose A; Tsai J; Li D
    Clin Drug Investig; 2012 Jun; 32(6):373-85. PubMed ID: 22559255
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the effects of citalopram and escitalopram on 5-Ht-mediated neuroendocrine responses.
    Nadeem HS; Attenburrow MJ; Cowen PJ
    Neuropsychopharmacology; 2004 Sep; 29(9):1699-703. PubMed ID: 15127082
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of cocaine alone and in combination with mazindol in human cocaine abusers.
    Preston KL; Sullivan JT; Berger P; Bigelow GE
    J Pharmacol Exp Ther; 1993 Oct; 267(1):296-307. PubMed ID: 8229755
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combining a dopamine agonist and selective serotonin reuptake inhibitor for the treatment of depression: a double-blind, randomized pilot study.
    Franco-Chaves JA; Mateus CF; Luckenbaugh DA; Martinez PE; Mallinger AG; Zarate CA
    J Affect Disord; 2013 Jul; 149(1-3):319-25. PubMed ID: 23517885
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder.
    Baldwin DS; Cooper JA; Huusom AK; Hindmarch I
    Int Clin Psychopharmacol; 2006 May; 21(3):159-69. PubMed ID: 16528138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.